Form 4: Collegium Pharmaceutical Executive Scott Dreyer Reports Changes in Beneficial Ownership
SEC Form 4 Filing
EVP & Chief Commercial Officer Scott Dreyer reports acquisition and disposal of Collegium Pharmaceutical stock and derivative securities due to vesting of restricted stock units and performance share units.
Summary
- Scott Dreyer, EVP & Chief Commercial Officer of Collegium Pharmaceutical, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On February 10, 2025, Dreyer acquired 45,016 shares of common stock through the grant of restricted stock units (RSUs) at $0.
- An additional 26,411 shares were acquired due to the vesting of performance share units (PSUs) at $0.
- Dreyer disposed of 7,953 shares at $30.52 to cover withholding taxes upon the vesting of PSUs.
- He also disposed of 21,670 shares at $30.52 to cover withholding taxes upon the vesting of RSUs.
- Following these transactions, Dreyer beneficially owns 147,706 shares of Collegium Pharmaceutical common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The vesting of RSUs and PSUs suggests the company is meeting performance targets. The sales are related to tax obligations, which is a normal occurrence.
Positives
- The vesting of RSUs and PSUs indicates that the company is meeting performance targets and rewarding its executives.
- The grant of RSUs incentivizes the executive to remain with the company.
Future Outlook
The RSUs will continue to vest in equal annual installments over the following two-year period after February 10, 2026, subject to continued service.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may view the vesting of RSUs and PSUs as a positive sign, indicating that the company is meeting its performance goals.
- Employees may be motivated by the fact that executives are being rewarded for their performance.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of earliest transaction, grant of RSUs, vesting of PSUs, and stock disposals for tax withholding. |
| 02/10/2026 | First vesting date for one-third (33%) of the granted RSUs. |
| 02/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.